This 25-mer oligonucleotide was able to correct aberrant splicing in different cell types, including dermal fibroblast and B-lymphocyte cell lines derived from HGPS patients, leading to a significant decrease in the levels of progerin in these cells. Here, LMNA is linked to Hutchinson-Gilford progeria syndrome.